Clinical Trials Logo
  1. Home
  2. Crow's Feet
  3. NCT06021418

Efficacy and Safety of DKB-119 in Patients in Crow's Feet

Crow's Feet Clinical Trial

Official title:
A Single Center, Randomized, Subject and Evaluator Blinded, Split-face, Pivotal Clinical Trial to Evaluate the Efficacy and Safety of DKB-119 in Crow's Feet

Clinical Trial Summary

To prove the non-inferiority of DKB-119 by evaluating the injecting efficacy and safety DKB-119 and control for patients in crow's feet

Clinical Trial Description

A single center, randomized, subject and evaluator blinded, split-face, pivotal clinical trial ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06021418
Study type Interventional
Source Dongkook Pharmaceutical Co., Ltd.
Contact
Status Active, not recruiting
Phase N/A
Start date November 2, 2020
Completion date October 31, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01951742 - Dose Finding Study In Subjects With Crow's Feet Phase 2
Completed NCT03326856 - ET-01 in Subjects With Lateral Canthal Lines Phase 2
Completed NCT03839693 - ET-01 in Subjects With Lateral Canthal Lines, LCL-208 Phase 2
Completed NCT00888914 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT01358695 - Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet Phase 2
Completed NCT01124565 - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00968825 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Recruiting NCT04818203 - A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet Phase 1/Phase 2
Active, not recruiting NCT04985916 - ET-01 in Subjects With Lateral Canthal Lines, LCL-210 Phase 2
Completed NCT01064518 - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT03912805 - ET-01 in Subjects With Lateral Canthal Lines, LCL-209 Phase 2
Completed NCT00968942 - Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT03655691 - ET-01 in Subjects With Lateral Canthal Lines, LCL-207 Phase 2
Completed NCT01124552 - A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2